Magnetic resonance-based imaging biopsy with signatures including topological Betti number features for prediction of primary brain metastatic sites

• Published in: Physical and engineering sciences in medicine 2023-12, Vol.46 (4), p.1411-1426
• Main Authors: Egashira, Mai, Arimura, Hidetaka, Kobayashi, Kazuma, Moriyama, Kazutoshi, Kodama, Takumi, Tokuda, Tomoki, Ninomiya, Kenta, Okamoto, Hiroyuki, Igaki, Hiroshi
• Format: Article
• Language: English
• Subjects: Biological and Medical Physics; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Biomedicine; Biophysics; Biopsy; Brain - diagnostic imaging; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - secondary; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms - diagnostic imaging; Magnetic Resonance Spectroscopy; Medical and Radiation Physics; Retrospective Studies; Scientific Paper
• ISSN: 2662-4729; 2662-4737
• DOI: 10.1007/s13246-023-01308-6

This study incorporated topology Betti number (BN) features into the prediction of primary sites of brain metastases and the construction of magnetic resonance-based imaging biopsy (MRB) models. The significant features of the MRB model were selected from those obtained from gray-scale and three-dimensional wavelet-filtered images, BN and inverted BN (iBN) maps, and clinical variables (age and gender). The primary sites were predicted as either lung cancer or other cancers using MRB models, which were built using seven machine learning methods with significant features chosen by three feature selection methods followed by a combination strategy. Our study dealt with a dataset with relatively smaller brain metastases, which included effective diameters greater than 2 mm, with metastases ranging from 2 to 9 mm accounting for 17% of the dataset. The MRB models were trained by T1-weighted contrast-enhanced images of 494 metastases chosen from 247 patients and applied to 115 metastases from 62 test patients. The most feasible model attained an area under the receiver operating characteristic curve (AUC) of 0.763 for the test patients when using a signature including features of BN and iBN maps, gray-scale and wavelet-filtered images, and clinical variables. The AUCs of the model were 0.744 for non-small cell lung cancer and 0.861 for small cell lung cancer. The results suggest that the BN signature boosted the performance of MRB for the identification of primary sites of brain metastases including small tumors.